Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Capital Expenditures: 2019-2024

Historic Capital Expenditures for Agilon Health (AGL) over the last 6 years, with FY2024 value amounting to $13.3 million.

  • Agilon Health's Capital Expenditures fell 1015.85% to $3.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.1 million, marking a year-over-year increase of 761.2%. This contributed to the annual value of $13.3 million for FY2024, which is 1629.19% down from last year.
  • Agilon Health's Capital Expenditures amounted to $13.3 million in FY2024, which was down 1629.19% from $15.8 million recorded in FY2023.
  • In the past 5 years, Agilon Health's Capital Expenditures ranged from a high of $15.8 million in FY2023 and a low of $1.8 million during FY2020
  • For the 5-year period, Agilon Health's Capital Expenditures averaged around $10.6 million, with its median value being $13.3 million (2024).
  • In the last 5 years, Agilon Health's Capital Expenditures plummeted by 3862.38% in 2020 and then surged by 26980.28% in 2021.
  • Over the past 5 years, Agilon Health's Capital Expenditures (Annual) stood at $1.8 million in 2020, then surged by 269.8% to $6.6 million in 2021, then skyrocketed by 135.01% to $15.4 million in 2022, then increased by 2.62% to $15.8 million in 2023, then dropped by 16.29% to $13.3 million in 2024.
  • Its Capital Expenditures stands at $13.3 million for FY2024, versus $15.8 million for FY2023 and $15.4 million for FY2022.